Evvy Launches Male Partner Treatment to Prevent Recurrence of Bacterial Vaginosis

The Antibiotic Regimen, Based on the Latest Research, Represents a Long-Overdue Evolution in BV Care

NEW YORK--(BUSINESS WIRE)--Evvy, the pioneering vaginal healthcare platform, today announces the launch of its Male Partner BV Treatment, a research-backed, two-part antibiotic regimen designed to help reduce bacterial vaginosis (BV) recurrence in women by treating their male partners.

BV is the most common vaginal infection in women of reproductive age, with over half of those treated experiencing recurrence within six months. Yet, care has long focused on women, ignoring a critical piece of the puzzle: their partners. A recent study published in the New England Journal of Medicine found that treating male partners with a combination of oral and topical antibiotics significantly reduces the risk of BV coming back.

“For decades, BV treatment has failed to account for the full picture, ” says Dr. Kate McLean, OB-GYN and Chief Medical Officer at Evvy. “Emerging research validates what so many of us in women’s health have suspected — untreated male partners can be a major reason BV keeps coming back. By offering science-backed treatment for male partners, we’re offering support to both in achieving lasting relief.”

Evvy’s Male Partner BV Treatment includes a combination of oral metronidazole and topical clindamycin, taken twice daily for seven days, if prescribed by a licensed clinician. Available through Evvy’s platform for $129, the treatment is shipped discreetly to the male patient’s home with no pharmacy visits needed.

“Recurrent BV can be incredibly exhausting and isolating,” said Priyanka Jain, CEO and Co-Founder of Evvy. “With this launch, we are empowering couples to tackle it together, with transparency, science, and zero shame.”

Evvy remains the only platform offering a comprehensive ecosystem for vaginal health, combining metagenomic vaginal microbiome testing, STI screening, precision care, and science-backed supplements. This latest innovation builds on Evvy’s mission to provide precision vaginal healthcare based on the latest scientific research. The Male Partner BV Treatment is available now on www.evvy.com.

About Evvy:

Evvy is closing the gender health gap through novel biomarker discovery in the vaginal microbiome. Evvy’s groundbreaking Vaginal Health Test is the world’s only certified, peer-reviewed vaginal microbiome test to uncover 700+ microbes with a single, at-home swab. Combined with precision treatment pathways and 1-1 coaching, Evvy provides over 50,000 women with data-driven, personalized healthcare for vaginal infections, fertility, menopause, and more. Evvy has built the world’s largest dataset on the vaginal microbiome, and they are pioneering novel research to transform female health outcomes.